Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
EGFR-TKI Combined With Concurrent or Sequential Chemotherapy for Patients of Gradual Progression
ClinicalTrials.gov study NCT03544814. IPD Sharing: NO. Countries: 0. Publications: 1.
Utilizing Long-read Sequencing to Investigate the EGFR Landscape of EGFR Positive Lung Cancer Patients
ClinicalTrials.gov study NCT06659458. IPD Sharing: YES. Countries: 1. Publications: 0.
Cabozantinib and Erlotinib for Patients With EGFR and c-Met Co-expressing Metastatic Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT03213626. IPD Sharing: NO. Countries: 1. Publications: 0.
Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients
ClinicalTrials.gov study NCT04512430. IPD Sharing: NO. Countries: 1. Publications: 0.
Value of F-18 FDG PET/CT for the Prediction of EGFR Mutation in Lung Cancer Patients
ClinicalTrials.gov study NCT06520189. IPD Sharing: Not stated. Countries: 0. Publications: 4.
Erlotinib and AT-101 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations
ClinicalTrials.gov study NCT00988169. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced Malignancies
ClinicalTrials.gov study NCT04172597. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I/II Study of Ibrutinib in Previously Treated Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT02321540. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT06685718. IPD Sharing: YES. Countries: 7. Publications: 0.
A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease
ClinicalTrials.gov study NCT04881448. IPD Sharing: YES. Countries: 4. Publications: 0.
Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs
ClinicalTrials.gov study NCT06567015. IPD Sharing: YES. Countries: 7. Publications: 0.
Radiation and Cetuximab Plus Intratumoral EGFR Antisense DNA in Locally Advanced Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT01592721. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR Mutations
ClinicalTrials.gov study NCT01287754. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC
ClinicalTrials.gov study NCT03989115. IPD Sharing: NO. Countries: 2. Publications: 0.
Iressa Re-Challenge in Advanced NSCLC EGFR M+ Patients Who Responded to Gefitinib USed as 1st Line or Previous Treatment
ClinicalTrials.gov study NCT01530334. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Olaparib (LYNPARZA) Plus Durvalumab (IMFINZI) in EGFR-Mutated Adenocarcinomas That Transform to Small Cell Lung Cancer (SCLC) and Other Neuroendocrine Tumors
ClinicalTrials.gov study NCT04538378. IPD Sharing: YES. Countries: 1. Publications: 0.
Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer
ClinicalTrials.gov study NCT03891615. IPD Sharing: YES. Countries: 1. Publications: 0.
Furmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety Study
ClinicalTrials.gov study NCT07365410. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib
ClinicalTrials.gov study NCT03076164. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations
ClinicalTrials.gov study NCT06716580. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.